Publication
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols
Ozgur Can Eren, Pelin Bagci, Serdar Balci, Nobuyuki Ohike, Burcu Saka, Cenk Sokmensuer, Can Berk Leblebici, Yue Xue, Michelle D. Reid, Alyssa M. Krasinskas, David Kooby, Shishir K. Maithel, Juan Sarmiento, Jeanette D. Cheng, Orhun Cig Taskin, Yersu Kapran, Zeynep Cagla Tarcan, Claudio Luchini, Aldo Scarpa, Olca Basturk, N. Volkan Adsay
Annals of Surgical Oncology, July 2024, Springer Science + Business Media
DOI: 10.1245/s10434-024-15632-y